Krishna Institute of Medical Sciences Limited (KIMS) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Krishna Institute of Medical Sciences (KIMS) enters the Q1 FY27 results season navigating a period of significant capacity expansion and balance sheet restructuring. Investors will be focused on the margin recovery trajectory amidst persistent drag from new hospital ramp-ups and the impact of recent capital raising on finance costs.

Krishna Institute of Medical Sciences Limited Q1 Results Date and Time

The board meeting is scheduled for August 03, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

A conference call is scheduled for August 04, 2026, at 10:00 AM IST, hosted by IIFL Capital.

What to expect from Krishna Institute of Medical Sciences Limited's Q1 FY27 results

The primary focus for Q1 FY27 is the margin recovery path, as the company works to reverse the EBITDA margin compression seen in FY26, which ended at 21.1%. With the Palakkad hospital acquisition and Bengaluru facility expansion adding significant capacity, the company is managing a transition where bed additions currently outpace patient ramp-up, keeping occupancy in the 47-50% band. Finance costs remain a critical watch item, as the Rs. 1,500 Cr QIP proceeds raised on June 19, 2026, provide a path to deleveraging, though the full impact on interest expense will likely manifest from Q2 FY27 onwards. Management has maintained a long-term growth outlook, targeting a net debt/EBITDA ratio of approximately 1.0x following the recent capital raise. The upcoming call will likely address the pace of insurance empanelment for new hospitals in Thane, Nashik, and Bengaluru, which remains a key operational bottleneck.

Key Things To Watch

Performance vs Guidance Tracking: Monitoring progress against management's stated FY27 and open-ended targets.

• Telangana EBITDA growth — 10-12% target for FY27 — track Q1 performance
• Bengaluru occupancy — 35-40% target by end FY27 — currently ~20%
• Palakkad break-even — June/July 2026 target — check status for Q1 FY27
• Net debt reduction — ~Rs. 1,000 Cr target post QIP — check Q1 progress

Strategic Updates: Status of major expansion projects and capital allocation.

• Utilization of QIP proceeds for debt repayment and operational losses
• Kondapur 500-bed hospital commissioning status
• Preferential warrant conversion progress following EGM approval

Operating metric trajectory: Key performance indicators for new and existing clusters.

• ARPOB trend toward Rs. 50,000-55,000 target
• Occupancy improvement in new clusters including Maharashtra and Kerala
• O&M unit ramp-up for Sangli, Guntur, and Thrissur

Risks and headwinds to monitor: External factors impacting operational efficiency.

• Insurance empanelment delays for Thane, Nashik, and Bangalore due to GIC common empanelment initiative
• Competitive intensity in Hyderabad and Bangalore markets
• Elevated finance costs pending deployment of QIP proceeds